Skip to main content
OpenTrials
Completed

NCT Number: NCT04694911

Development of the Oncology Opportunity Cost Assessment Tool

This study develops and tests an instrument to measure opportunity costs called the Oncology Opportunity Cost Assessment Tool (OOCAT) in cancer patients. Patients experience significant costs, both direct financial as well as indirect costs, associated with seeking cancer treatment. While the direct financial impact of care on patients is receiving increased attention, other important consequences, such as opportunity cost, remain largely unmeasured. Opportunity cost is an economics term that refers to the loss of potential benefits from other options when one option is chosen - if resources are used for one purpose, they are no longer available for the next best option. The information and knowledge gained from this study may help researchers develop the OOCAT, which may allow them to understand the opportunity cost of treatment for each patient. The OOCAT may then be used to determine not just the best medications for patients, but also the best comprehensive treatment plan that will allow them to get the right treatment in the right place at the right time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hematopoietic and Lymphoid Cell Neoplasm Hematologic Diseases Hematologic Neoplasms Hemic and Lymphatic Diseases Malignant Solid Neoplasm Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Sidney Kimmel Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Treated for cancer at one of the 3 participating sites (Jefferson Center City, Jefferson Methodist Hospital, Jefferson Abington)
  • English speaking
  • Able to attend and participate in a focus group

Exclusion criteria

  • Treated at a Jefferson site other than the ones mentioned
  • Non-English Speaking

Treatment and study plan

Focus Group

Behavioral

Participate in focus group

interview

Other

Complete cognitive interview

Research or Clinical Assessment Tool

Other

Receive OOCAT

Other names: Clinical Assessment Tool, Clinical Assessment Tool, Clinical or Research Assessment Tool

Primary outcomes

  1. Patient-level opportunity costs associated with oncology care

    Time frame: 1 Day of Interview

    Patient-identified themes that contribute to opportunity cost will be generated via patient focus groups

  2. Development of the Oncology Opportunity Cost Assessment Tool (OOCAT)

    Time frame: 1 Day of Interview

    Will organize themes into domains and will generate items representing each of the themes for inclusion in an instrument designed to measure patient opportunity cost of seeking care. Will perform cognitive interviews with a random sampling of patients from the cancer center to test initial instrument items to ensure content validity and clarity of each item.

  3. Implementation of OOCAT

    Time frame: 1 Day of OOCAT administration

    Will test the instrument as developed with patients receiving oncology care across the Jefferson Health System to gather preliminary data informing the reliability of the scale to measure opportunity cost of seeking care.

Sponsors and collaborators

Lead sponsor

Thomas Jefferson University

Other

Registry information

Official study title

Development of the Oncology Opportunity Cost Assessment Tool (OOCAT)

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Jan 5, 2021
Registry last updated
Apr 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.